Is Vertex Pharmaceuticals Incorporated (VRTX) a Buy, Sell, or Hold?
NASDAQ : VRTX
Vertex Pharmaceuticals Incorporated — Competitors
$477.36 USD
$4.27 (0.9%)
- Volume
- 1.25M
- Average Volume
- 1.52M
- Market Capitalization
- $121.16B
- P/E Ratio
- 28.06
- Dividend Yield
- 0.00%
- Price Target
- $576.00
- Year High
- $533.67
- Year Low
- $362.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.02
VRTX vs. The Competition
| Properties | VRTX | ARGX | BMY | CVS |
|---|---|---|---|---|
| Market Cap | $121.16B | $57.1B | $126.79B | $137.47B |
| Shares Outstanding | $253.81M | $62.19M | $2.04B | $1.28B |
| P/E Ratio | 28.06 | 33.21 | 17.44 | 46.64 |
| EPS | 17.07 | 27.41 | 3.56 | 2.3 |
| Day Low | 472.7 | 910.09 | 61.62 | 106.91 |
| Day High | 483.9999 | 935.88 | 62.82 | 108.39 |
| Year Low | 362.5 | 590.78 | 42.52 | 58.99 |
| Year High | 533.67 | 953.58 | 62.89 | 110.68 |
| Average Price 50 | 464.2978 | 864.28 | 57.4484 | 100.0934 |
| Average Price 200 | 451.18427 | 828.1832 | 55.0763 | 83.8518 |
| Volume | 1.25M | 324.11K | 11.98M | 4.04M |
| Average Volume | - | - | - | - |